arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

CVS HEALTH Corp

CVS
$95.69 ▼ -0.47 (-0.49%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
74 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Bullish
auto_awesome

Analytical Summary

CVS HEALTH Corp shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $121.8B
Dividend Yield 0.69%
Revenue Growth 6.2%
Op. Margin 4.7%
ROIC 4.5%
FCF / Share $2.67
Trailing P/E 41.4x
Price / Book 1.6x
FCF Yield 2.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$100.43B
↑ +6.2%
Net Income Profit after all expenses
$2.94B
↑ +65.4%
Operating Margin Operating profit as % of sales
4.7%
↑ +133.2% 31th
FCF / Share Free cash flow per share
$2.67
↓ -11.7%
Long-Term Debt Long-term obligations
$63.48B
↓ -3.4%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
32
Returns
48
Financial Health
77
Cash Quality
94

Dividend History

Dividend / share · sourced from SEC filings
$2.66 Latest / share
+0.0% YoY
+8.4% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters